Phone Advice Line Guidelines for Children (2-17 years) or Adults (≥ 18 years) with Possible COVID-19
03/30/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/30/2020. This web page provides a script, with an accompanying decision algorithm and messages, for healthcare providers providing phone advice for children (2-17 years) or adults (≥ 18 years) with possible COVID-19. (Text)
03/30/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/30/2020. This two-page Legal Sidebar provides a list of resources discussing legal topics related to the COVID-19 pandemic, including Health Care, Health Coverage, and Medical Countermeasures; Quarantine, Isolation, and Travel Restrictions; Medical Goods, Procurement, and Government Contracts; Economic Issues; and Elections. (PDF)
03/30/2020 12:00 AM EDT
Source: United Nations Office for the Coordination of Humanitarian Affairs (OCHA). Published: 3/30/2020. This map shows the number of confirmed cases and deaths from the coronavirus disease (COVID-19) in locations with Humanitarian Response Plans (HRPs) or other types of response plans. The countries include Afghanistan, Burkina Faso, Burundi, Cameroon, Сentral African Republic, Chad, Democratic Republic of the Congo, Ethiopia, Haiti, Iraq, Libya, Mali, Myanmar, Niger, Nigeria, occupied Palestinian territory, Somalia, South Sudan, Sudan, Syria, Ukraine, Venezuela, and Yemen. (Text)
03/30/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/30/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the NeuMoDx™ SARS-CoV-2 Assay, which received an Emergency Use Authorization from the Food and Drug Administration on March 30, 2020. The NeuMoDx™ SARS-CoV-2 Assay is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
03/30/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/30/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, which received an Emergency Use Authorization from the Food and Drug Administration on March 30, 2020. The QIAstat-Dx Respiratory SARS-CoV-2 Panel is authorized for use on respiratory specimens collected from patients suspected of COVID-19 by their healthcare provider. (PDF)
03/30/2020 12:00 AM EDT
Source: American Society for Healthcare Engineering (ASHE). Published: 3/30/2020. As a result of the COVID-19 pandemic, the nation’s hospitals are preparing for an exponential number of patients in need of care. It is vital to seek and implement ways to increase patient capacity across the country by making additional spaces for our patients. This web page provides guidance to help healthcare facilities create those spaces. (Text)
Coronavirus Disease (COVID-19) FAQs for Administrators, Staff, People Who Are Incarcerated, Families
03/28/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/28/2020. This web page provides answers to questions about preparing a correction or detention facility for COVID-19, preventing the spread of COVID-19, and preparing people who are incarcerated. The information provided in these FAQs about COVID-19 does not cover all questions or issues faced by custodial settings (prisons, jails, and detention facilities), and may need to be adapted based on individual facilities’ physical space, staffing, population, operations, and other resources and conditions. (Text)
03/25/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/25/2020. This five-page report presents selected information and resources relevant to the domestic public health response to COVID-19 in containing and mitigating the spread and impact of the disease. It provides a table for A Snapshot of the Domestic Public Health Response to COVID-19, as of March 25, 2020, from national and international sources. (PDF)
03/23/2020 12:00 AM EDT
Source: American Society for Healthcare Engineering (ASHE). Published: 3/23/2020. During the COVID-19 pandemic, it is important to examine changing facility needs with the assistance of qualified facilities professionals who can assess the facilities engineering controls and patient flow, and help verify that a COVID-19 response will properly protect patients. This web page recommends and details using a multidisciplinary approach. (Text)
03/20/2020 12:00 AM EDT
Source: American Society for Healthcare Engineering (ASHE). Published: 3/20/2020. In an effort to reduce personal protective equipment, a suggestion has been provided to move IV pumps outside of the patient room and extend the tubing to the patient. This web page provides a location chart and checklist to help hospital facilities professionals assist in relocating patient equipment from negative pressure rooms to avoid repeated entry into the room to check on patient equipment. (Text)
03/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/19/2020. This web page provides answers to frequently asked questions about laboratory biosafety and COVID-19, with questions in categories of Specimen Handling, and Specimen Packing and Shipping. (Text)
03/17/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/17/2020. This four-page report summarizes legal issues regarding travel and entry restrictions, quarantine, and isolation related to the COVID-19 pandemic. It also discusses possible legal issues that may arise in the future as the pandemic continues. (PDF)
03/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 3/2020. This course provides principles, minimum requirements, and technical specifications to design and set up severe acute respiratory infection (SARI)-related facilities though short lectures and technical tutorials. Participants will learn to draft and evaluate a SARI treatment center layout, including triage and different risk areas, with clear and rational flows of people and material; describe different types of ventilation and exhausted air treatments; and describe the referral pathway and patient’s journey. (Video or Multimedia)
03/01/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 3/2020. This 13-page guidance provides a policy to help expand the availability of general use face masks for the general public and particulate filtering facepiece respirators (including N95 respirators) for healthcare professionals during the COVID-19 pandemic. (PDF)
06/01/2019 12:00 AM EDT
Source: Northwest Healthcare Response Network. Published: 6/2019. The guidelines in this 20-page document seek to balance the need for sharing meaningful intelligence and situational awareness within the healthcare and emergency management community to facilitate an effective, coordinated response to incidents and events while respecting the autonomy of individual healthcare organizations to manage sensitive organizational information. This plan is applicable for a standard situational awareness process for healthcare organizations from within the Northwest Healthcare Response Network coalition service area. (PDF)
.png)
No hay comentarios:
Publicar un comentario